Materials • Major Chemicals
$0.25 ▼ -0.01
(-3.44%)
MKT CAP: $12.2M • VOL: 62.7K
52W L $0 52W H $2
ROARABLE / RQD
D • 46/100
PIOTROSKI
4 / 9
LOOP // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2026-02-28 | FY 2024
FILED 2025-02-28 | FY 2023
FILED 2024-02-29 |
|---|---|---|---|
| Revenue (Total Sales) | $514.0K | $10.9M | $153.0K |
| YoY Revenue Growth % | -95.3% | +7017.0% | — |
| Gross Profit | $133.0K | $10.7M | — |
| Gross Margin % | 25.9% | 98.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $0 | $0 | $0 |
| Operating Margin % | — | — | — |
| Net Income (GAAP) | -$12.3M | -$15.1M | -$21.1M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$10.1M | -$2.1M | -$18.0M |
| Capital Expenditures (CapEx) | — | $0 | — |
| Free Cash Flow (FCF) | -$10.1M | -$2.1M | -$18.0M |
| FCF Margin % | -80.0% | -19.5% | -80.0% |
| Return on Invested Capital (ROIC %) | — | — | — |
| Cash & Short-Term Equivalents | $5.2M | $323.0K | — |
| Total Debt (Short + Long Term) | $2.5M | $2.7M | — |
| Total Stockholders' Equity | -$7.3M | -$6.9M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR LOOP.